• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人凝血因子 VIII 的一个大片段(约相当于 95 kDa)对于体外促凝血活性而言并非必需。

A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity.

作者信息

Toole J J, Pittman D D, Orr E C, Murtha P, Wasley L C, Kaufman R J

出版信息

Proc Natl Acad Sci U S A. 1986 Aug;83(16):5939-42. doi: 10.1073/pnas.83.16.5939.

DOI:10.1073/pnas.83.16.5939
PMID:3016730
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC386412/
Abstract

Factor VIII (antihemophilic factor) is a high molecular weight plasma glycoprotein that participates in the blood clotting cascade. The recent cloning and sequence analysis of the cDNA encoding human factor VIII revealed an obvious domain structure for the protein, which can be represented as A1-A2-B-A3-C1-C2. We now report the DNA sequence analysis of porcine exons encoding the entire B domain and part of the A2 and A3 domains. We found an unusually high degree of porcine-human amino acid sequence divergence in the B region compared with the limited sequence available for other regions of the porcine factor VIII molecule. In addition to sequence divergence, there are numerous gaps in the porcine B domain totalling over 200 amino acids. Recombinant DNA techniques were used to effect the removal of large segments of DNA encoding the B domain from the full-length human factor VIII cDNA. These constructs directed the synthesis of biologically active factor VIII when introduced into mammalian cells despite the deletion of up to 38% of the factor VIII molecule.

摘要

凝血因子VIII(抗血友病因子)是一种高分子量血浆糖蛋白,参与血液凝固级联反应。最近对编码人凝血因子VIII的cDNA进行的克隆和序列分析揭示了该蛋白明显的结构域结构,可表示为A1-A2-B-A3-C1-C2。我们现在报告猪外显子的DNA序列分析,这些外显子编码整个B结构域以及部分A2和A3结构域。我们发现,与猪凝血因子VIII分子其他区域有限的可用序列相比,B区域猪与人的氨基酸序列差异程度异常高。除了序列差异外,猪B结构域还有许多缺口,总共超过200个氨基酸。利用重组DNA技术从全长人凝血因子VIII cDNA中去除编码B结构域的大片段DNA。尽管缺失了高达38%的凝血因子VIII分子,但这些构建体在引入哺乳动物细胞时仍能指导合成具有生物活性的凝血因子VIII。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b211/386412/7a95300dc6f1/pnas00320-0198-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b211/386412/7a95300dc6f1/pnas00320-0198-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b211/386412/7a95300dc6f1/pnas00320-0198-a.jpg

相似文献

1
A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity.人凝血因子 VIII 的一个大片段(约相当于 95 kDa)对于体外促凝血活性而言并非必需。
Proc Natl Acad Sci U S A. 1986 Aug;83(16):5939-42. doi: 10.1073/pnas.83.16.5939.
2
Construction and characterization of an active factor VIII variant lacking the central one-third of the molecule.一种缺失分子中部三分之一的活性因子VIII变体的构建与特性分析
Biochemistry. 1986 Dec 30;25(26):8343-7. doi: 10.1021/bi00374a001.
3
Synthesis of biologically active deletion mutants of human factor VIII:C.人凝血因子VIII:C生物活性缺失突变体的合成
Behring Inst Mitt. 1988 Apr(82):16-25.
4
A 110-amino acid region within the A1-domain of coagulation factor VIII inhibits secretion from mammalian cells.凝血因子 VIII 的 A1 结构域内一个 110 个氨基酸的区域可抑制哺乳动物细胞的分泌。
J Biol Chem. 1995 Apr 28;270(17):10297-303. doi: 10.1074/jbc.270.17.10297.
5
The cDNA and derived amino acid sequence of porcine factor VIII.猪凝血因子VIII的cDNA及推导的氨基酸序列。
Blood. 1996 Dec 1;88(11):4209-14.
6
Identification of porcine coagulation factor VIII domains responsible for high level expression via enhanced secretion.通过增强分泌鉴定负责高水平表达的猪凝血因子VIII结构域。
J Biol Chem. 2004 Feb 20;279(8):6546-52. doi: 10.1074/jbc.M312451200. Epub 2003 Dec 1.
7
Role of the B domain for factor VIII and factor V expression and function.B结构域对凝血因子VIII和凝血因子V表达及功能的作用。
Blood. 1994 Dec 15;84(12):4214-25.
8
Biological activity of recombinant factor VIII variants lacking the central B-domain and the heavy-chain sequence Lys713-Arg740: discordant in vitro and in vivo activity.缺乏中央B结构域及重链序列Lys713 - Arg740的重组因子VIII变体的生物学活性:体外和体内活性不一致
Br J Haematol. 1993 Sep;85(1):133-42. doi: 10.1111/j.1365-2141.1993.tb08656.x.
9
Novel forms of B-domain-deleted recombinant factor VIII molecules. Construction and biochemical characterization.新型B结构域缺失重组因子VIII分子。构建与生化特性分析。
Eur J Biochem. 1995 Aug 15;232(1):19-27. doi: 10.1111/j.1432-1033.1995.tb20776.x.
10
Biosynthesis, assembly and secretion of coagulation factor VIII.凝血因子 VIII 的生物合成、组装与分泌。
Blood Coagul Fibrinolysis. 1997 Dec;8 Suppl 2:S3-14.

引用本文的文献

1
Use of an oversized AAV8 vector for CPS1 deficiency results in long-term survival and ammonia control.使用超大的AAV8载体治疗CPS1缺乏症可实现长期生存并控制血氨水平。
Mol Ther Nucleic Acids. 2025 Feb 3;36(1):102470. doi: 10.1016/j.omtn.2025.102470. eCollection 2025 Mar 11.
2
A Comparative Review on the Production of Factor VIII in Human and Non-human Hosts.人类和非人类宿主中因子VIII产生的比较综述。
Curr Pharm Des. 2025;31(18):1417-1429. doi: 10.2174/0113816128327353241121050134.
3
Cellular stress and coagulation factor production: when more is not necessarily better.

本文引用的文献

1
Coagulation factors V and VIII and ceruloplasmin constitute a family of structurally related proteins.凝血因子V、VIII和铜蓝蛋白构成了一个结构相关蛋白家族。
Proc Natl Acad Sci U S A. 1984 Nov;81(22):6934-7. doi: 10.1073/pnas.81.22.6934.
2
Molecular cloning of a cDNA encoding human antihaemophilic factor.编码人抗血友病因子的cDNA的分子克隆
Nature. 1984;312(5992):342-7. doi: 10.1038/312342a0.
3
Structure of human factor VIII.人凝血因子VIII的结构
细胞应激与凝血因子生成:过犹不及。
J Thromb Haemost. 2023 Dec;21(12):3329-3341. doi: 10.1016/j.jtha.2023.10.005. Epub 2023 Oct 14.
4
Bacterial Production of Recombinant Coagulation Factor VIII Domains.细菌生产重组凝血因子 VIII 结构域。
Medicina (Kaunas). 2023 Apr 1;59(4):694. doi: 10.3390/medicina59040694.
5
Ectopic clotting factor VIII expression and misfolding in hepatocytes as a cause for hepatocellular carcinoma.肝细胞中异位凝血因子 VIII 的表达和错误折叠是肝细胞癌的原因。
Mol Ther. 2022 Dec 7;30(12):3542-3551. doi: 10.1016/j.ymthe.2022.10.004. Epub 2022 Oct 14.
6
Characteristics of BAY 2599023 in the Current Treatment Landscape of Hemophilia A Gene Therapy.在当前血友病 A 基因治疗的治疗环境中 BAY 2599023 的特点。
Curr Gene Ther. 2023;23(2):81-95. doi: 10.2174/1566523222666220914105729.
7
Liver gene therapy with intein-mediated F8 trans-splicing corrects mouse haemophilia A.内含肽介导 F8 反式剪接的肝脏基因治疗纠正小鼠血友病 A。
EMBO Mol Med. 2022 Jun 8;14(6):e15199. doi: 10.15252/emmm.202115199. Epub 2022 May 2.
8
Removal of single-site N-linked glycans on factor VIII alters binding of domain-specific monoclonal antibodies.VIII 因子单点 N-糖基化的去除改变了特异性单克隆抗体的结合。
J Thromb Haemost. 2022 Mar;20(3):574-588. doi: 10.1111/jth.15616. Epub 2021 Dec 17.
9
Minimal Essential Human Factor VIII Alterations Enhance Secretion and Gene Therapy Efficiency.最小必需人凝血因子VIII改变增强分泌和基因治疗效率。
Mol Ther Methods Clin Dev. 2020 Oct 22;19:486-495. doi: 10.1016/j.omtm.2020.10.013. eCollection 2020 Dec 11.
10
Factor VIII: Perspectives on Immunogenicity and Tolerogenic Strategies for Hemophilia A Patients.凝血因子VIII:对A型血友病患者免疫原性和免疫耐受策略的见解
Int J Mol Cell Med. 2020 Winter;9(1):33-50. doi: 10.22088/IJMCM.BUMS.9.1.33.
Nature. 1984;312(5992):337-42. doi: 10.1038/312337a0.
4
Expression of active human factor VIII from recombinant DNA clones.从重组DNA克隆中表达活性人凝血因子VIII。
Nature. 1984;312(5992):330-7. doi: 10.1038/312330a0.
5
Characterization of the human factor VIII gene.人类凝血因子VIII基因的特征分析。
Nature. 1984;312(5992):326-30. doi: 10.1038/312326a0.
6
Characterization of Factor V activation intermediates.凝血因子V激活中间体的表征
J Biol Chem. 1984 Mar 10;259(5):3187-96.
7
Clinical experience with polyelectrolyte-fractionated porcine factor VIII concentrate in the treatment of hemophiliacs with antibodies to factor VIII.聚电解质分级猪源凝血因子VIII浓缩物治疗血友病伴VIII因子抗体患者的临床经验
Blood. 1984 Jan;63(1):31-41.
8
Amplification and expression of sequences cotransfected with a modular dihydrofolate reductase complementary dna gene.与模块化二氢叶酸还原酶互补DNA基因共转染的序列的扩增与表达。
J Mol Biol. 1982 Aug 25;159(4):601-21. doi: 10.1016/0022-2836(82)90103-6.
9
Efficient infection of monkey cells with DNA of simian virus 40.用猴病毒40的DNA有效感染猴细胞。
Proc Natl Acad Sci U S A. 1981 Dec;78(12):7575-8. doi: 10.1073/pnas.78.12.7575.
10
SV40-transformed simian cells support the replication of early SV40 mutants.猴空泡病毒 40(SV40)转化的猿猴细胞支持早期 SV40 突变体的复制。
Cell. 1981 Jan;23(1):175-82. doi: 10.1016/0092-8674(81)90282-8.